KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?

Selcukbiricik F., Yildiz O., Tural D., Öztürk M. S. , Demir G., Ozguroglu M., ...More

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, 23 - 27 September 2011, vol.47 identifier